one8zero8 LLC Makes New Investment in Encompass Health Co. (NYSE:EHC)

one8zero8 LLC purchased a new stake in Encompass Health Co. (NYSE:EHC) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,265 shares of the company’s stock, valued at approximately $394,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Globeflex Capital L P grew its holdings in Encompass Health by 305.5% in the 4th quarter. Globeflex Capital L P now owns 42,739 shares of the company’s stock valued at $3,947,000 after buying an additional 32,200 shares in the last quarter. Madison Investment Advisors LLC acquired a new position in shares of Encompass Health during the 4th quarter valued at about $8,118,000. Tredje AP fonden purchased a new stake in shares of Encompass Health in the fourth quarter valued at about $1,847,000. Vestcor Inc increased its position in Encompass Health by 5.0% during the fourth quarter. Vestcor Inc now owns 60,775 shares of the company’s stock worth $5,613,000 after purchasing an additional 2,896 shares during the last quarter. Finally, Swiss National Bank raised its stake in Encompass Health by 0.7% during the fourth quarter. Swiss National Bank now owns 197,900 shares of the company’s stock worth $18,276,000 after purchasing an additional 1,300 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Insider Buying and Selling

In other news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the sale, the chief accounting officer now directly owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.10% of the stock is owned by insiders.

Encompass Health Price Performance

Shares of EHC opened at $96.11 on Monday. The company has a market cap of $9.68 billion, a P/E ratio of 21.55, a PEG ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a fifty-two week low of $74.45 and a fifty-two week high of $104.55. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The firm’s 50 day moving average price is $97.35 and its 200 day moving average price is $96.97.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, research analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.71%. Encompass Health’s dividend payout ratio (DPR) is 15.25%.

Analyst Ratings Changes

EHC has been the subject of a number of recent analyst reports. Barclays raised their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. Royal Bank of Canada reissued an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a research note on Tuesday, February 11th. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, KeyCorp upped their target price on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average target price of $107.67.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.